title: Photodynamic therapy with low-strength ALA, repeated applications and short contact periods (40-60 minutes) in acne, photoaging and vitiligo.
abstract: Topical aminolevulinic acid (ALA) photodynamic therapy (PDT) is currently being used for the treatment of actinic keratosis of the face and scalp. This study reports the results obtained after three to four treatments with ALA-PDT in patients with acne (n=12), photoaging (n=8) and vitiligo (n=6). ALA was applied on large areas (e.g., full face) and at very low strengths (1-2%). Side effects were minimal and self-limited.
authors.affiliation: Clínica Dermatológica Serrano,Valencia, Spain. gabriels@sesderma.com
authors.forename: Gabriel
authors.initials: G
authors.lastname: Serrano
authors.forename: Matilde
authors.initials: M
authors.lastname: Lorente
authors.forename: Madga
authors.initials: M
authors.lastname: Reyes
authors.forename: Fernando
authors.initials: F
authors.lastname: Millán
authors.forename: Adrián
authors.initials: A
authors.lastname: Lloret
authors.forename: Joaquín
authors.initials: J
authors.lastname: Melendez
authors.forename: Maria
authors.initials: M
authors.lastname: Navarro
authors.forename: Miguel
authors.initials: M
authors.lastname: Navarro
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000622:Aminolevulinic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D010778:Photochemotherapy / Q000009:adverse effects; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015595:Skin Aging / Q000187:drug effects*; D014820:Vitiligo / Q000188:drug therapy*
chemical_list: D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid